These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17651689)

  • 1. Nuclear thioredoxin-1 is required to suppress cisplatin-mediated apoptosis of MCF-7 cells.
    Chen XP; Liu S; Tang WX; Chen ZW
    Biochem Biophys Res Commun; 2007 Sep; 361(2):362-6. PubMed ID: 17651689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioredoxin is downstream of Smad7 in a pathway that promotes growth and suppresses cisplatin-induced apoptosis in pancreatic cancer.
    Arnold NB; Ketterer K; Kleeff J; Friess H; Büchler MW; Korc M
    Cancer Res; 2004 May; 64(10):3599-606. PubMed ID: 15150118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.
    Soini Y; Kahlos K; Näpänkangas U; Kaarteenaho-Wiik R; Säily M; Koistinen P; Pääakkö P; Holmgren A; Kinnula VL
    Clin Cancer Res; 2001 Jun; 7(6):1750-7. PubMed ID: 11410516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R; Nardinocchi L; Pistritto G; D'Orazi G
    Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of hyaluronan binding protein 1 (HABP1/p32/gC1qR) is associated with Cisplatin induced apoptosis.
    Kamal A; Datta K
    Apoptosis; 2006 May; 11(5):861-74. PubMed ID: 16544101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin.
    Kawahara N; Tanaka T; Yokomizo A; Nanri H; Ono M; Wada M; Kohno K; Takenaka K; Sugimachi K; Kuwano M
    Cancer Res; 1996 Dec; 56(23):5330-3. PubMed ID: 8968078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased BNip3 and decreased mutant p53 in cisplatin-sensitive PDT-resistant HT29 cells.
    Zacal N; Espiritu M; Singh G; Rainbow AJ
    Biochem Biophys Res Commun; 2005 Jun; 331(2):648-57. PubMed ID: 15850808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa-mediated lipid peroxidation.
    Kutuk O; Arisan ED; Tezil T; Shoshan MC; Basaga H
    Carcinogenesis; 2009 Sep; 30(9):1517-27. PubMed ID: 19578044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thioredoxin-1 phosphorylated at T100 is needed for its anti-apoptotic activity in HepG2 cancer cells.
    Chen X; Tang W; Liu S; Yu L; Chen Z
    Life Sci; 2010 Aug; 87(7-8):254-60. PubMed ID: 20619274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination.
    Hu J; Ma X; Lindner DJ; Karra S; Hofmann ER; Reddy SP; Kalvakolanu DV
    Oncogene; 2001 Jul; 20(31):4235-48. PubMed ID: 11464290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear redox-signaling is essential for apoptosis inhibition in endothelial cells--important role for nuclear thioredoxin-1.
    Schroeder P; Popp R; Wiegand B; Altschmied J; Haendeler J
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2325-31. PubMed ID: 17823364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin-1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicin.
    Berggren MI; Husbeck B; Samulitis B; Baker AF; Gallegos A; Powis G
    Arch Biochem Biophys; 2001 Aug; 392(1):103-9. PubMed ID: 11469800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
    Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
    Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
    Konstantakou EG; Voutsinas GE; Karkoulis PK; Aravantinos G; Margaritis LH; Stravopodis DJ
    Int J Oncol; 2009 Aug; 35(2):401-16. PubMed ID: 19578756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide induces thioredoxin-1 nuclear translocation: possible association with the p21Ras survival pathway.
    Arai RJ; Masutani H; Yodoi J; Debbas V; Laurindo FR; Stern A; Monteiro HP
    Biochem Biophys Res Commun; 2006 Oct; 348(4):1254-60. PubMed ID: 16914115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of heterogeneous nuclear ribonucleoprotein C1/C2 with a novel cis-regulatory element within p53 mRNA as a response to cytostatic drug treatment.
    Christian KJ; Lang MA; Raffalli-Mathieu F
    Mol Pharmacol; 2008 May; 73(5):1558-67. PubMed ID: 18296503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin.
    Avery-Kiejda KA; Zhang XD; Adams LJ; Scott RJ; Vojtesek B; Lane DP; Hersey P
    Clin Cancer Res; 2008 Mar; 14(6):1659-68. PubMed ID: 18310316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lentivirus-mediated HIF-1alpha knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells.
    Hao J; Song X; Song B; Liu Y; Wei L; Wang X; Yu J
    Cancer Gene Ther; 2008 Jul; 15(7):449-55. PubMed ID: 18421307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cisplatin-irradiation combination suggests that apoptosis is not a major determinant of clonogenic death.
    Lo Nigro C; Arnolfo E; Taricco E; Fruttero A; Russi EG; Lucio F; Ribero S; Comino A; Merlano M; Ungari S
    Anticancer Drugs; 2007 Jul; 18(6):659-67. PubMed ID: 17762394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.